Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.64-$4.57 |
Market Cap | $1.5B |
Shares Short | 131M |
Financials
See moreRevenue (12 Mos) | $263.5M |
Revenue Growth (YoY) | 17.7% |
Gross Profit (12 Mos) | $90.3M |
Diluted EPS | -$1.19 |
News
See moreYahoo Finance • 4 days ago
Iovance Biotherapeutics GAAP EPS of -$0.18 in-line, revenue of $86.71M beats by $5.7M
Yahoo Finance • 8 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 9 days ago
Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds?
Yahoo Finance • 22 days ago
Iovance Biotherapeutics (IOVA) Gives Update on Revenue Guidance, Lung Cancer Cure
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 838 |
